Pregnancy and Developmental Outcomes After Transfer of Reportedly Aneuploid or Mosaic Embryos

Trial ID or NCT#



recruiting iconRECRUITING


To determine how often embryos reported to be abnormal by preimplantation genetic testing result in liveborn infants. To evaluate whether the pregnancies that result from these embryos are higher risk for complications and whether the resulting babies have higher risk for health or developmental issues in the first five years after birth.

Official Title

Transfer of Aneuploid or Mosaic Embryos Following Preimplantation Genetic Testing

Eligibility Criteria

Ages Eligible for Study: 18 Years to 55 Years
Sexes Eligible for Study: Female
Accepts Healthy Volunteers: Yes
Inclusion Criteria:
  1. - Available aneuploid or mosaic embryos - No other acceptable embryos available - Willing to travel to Stanford for treatment - English language fluency
Exclusion Criteria:
  1. - Use of international donor eggs or sperm not tested according to FDA guidelines. - Living outside the United States - Embryos with Triploidy are not eligible for transfer in this protocol


Ruth Lathi, M.D.
Ruth Lathi, M.D.
Obstetrician and Gynecologist (OB-GYN), Fertility specialist
Professor of Obstetrics and Gynecology (Reproductive Endocrinology and Infertility)
Christina (Christy) Tise, MD, PhD

Contact us to find out if this trial is right for you.


Alleigh Boyd, MS